Exportar Publicação

A publicação pode ser exportada nos seguintes formatos: referência da APA (American Psychological Association), referência do IEEE (Institute of Electrical and Electronics Engineers), BibTeX e RIS.

Exportar Referência (APA) 
Greve, T. (2020). Does openness really incentivize openness?. Harvard University.
Exportar Referência (IEEE) 
T. Greve,  "Does openness really incentivize openness?", in Harvard University, 2020
Exportar BibTeX 
@misc{greve2020_1734884140834,
	author = "Greve, T.",
	title = "Does openness really incentivize openness?",
	year = "2020"
}
Exportar RIS 
TY  - CPAPER
TI  - Does openness really incentivize openness?
T2  - Harvard University
AU  - Greve, T.
PY  - 2020
AB  - In reason years, articles from a number of highly regarded magazines and journals have been discussing the benefits of openness in drug discovery as a way to reduce duplication of effect and development cost. Openness is being presented as open source, open data, open access and/or open science, where the later demands that internal laboratory notes are freely available and methods are shared, and hence, this concept opens up for a practice where others can contribute to an ongoing research. Basically, these so-called openness paradigms aim to enhance collaboration between different agents (e.g., companies and universities) with common interest in working together to develop new products/services, such as drugs. 

In this article, we go a step back to analyse whether or not openness really enhance collaboration between agents and if not, what can be done to restore the goal of these paradigms. We use game theory to analyse the mindset and behavior of the pharmaceutical industry.

ER  -